Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-04-04
2000-10-31
Saunders, David
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, A61K 3817, C07R 1474, A61P 700
Patent
active
061403059
ABSTRACT:
The invention relates generally to the gene, and mutations thereto, that are responsible for the disease hereditary hemochromatosis (HH). More particularly, the invention relates to the identification, isolation, and cloning of the DNA sequence corresponding to the normal and mutant HH genes, as well as the characterization of their transcripts and gene products. The invention also related to methods and the like for screening for HH homozygotes and further relates to HH diagnosis, prenatal screening and diagnosis, and therapies of HH disease, including gene therapeutics, protein and antibody based therapeutics, and small molecule therapeutics.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4434156 (1984-02-01), Trowbridge
patent: 4666927 (1987-05-01), Hider et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4711845 (1987-12-01), Gelfand et al.
patent: 4912118 (1990-03-01), Hider et al.
patent: 5075469 (1991-12-01), Chevion
patent: 5104865 (1992-04-01), Hider et al.
patent: 5116964 (1992-05-01), Capon
patent: 5185368 (1993-02-01), Peter et al.
patent: 5256676 (1993-10-01), Hider et al.
patent: 5328992 (1994-07-01), Peter et al.
patent: 5385918 (1995-01-01), Connell et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5420008 (1995-05-01), Nishida et al.
patent: 5424057 (1995-06-01), Peter et al.
Sood, et al., Proc. Natl. Acad. Sci. USA 73(1):616-620, Jan. 1981.
Gorski, J J. Immunol. 143(1):329-333, Jul. 1, 1989.
Patterson, et al., Mol. Cell Biol. 6:1590-1598, 1986.
Harlow, E., Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, p. 76, 1988.
Sevier, Ed. Clin. Chem. 27(11):1797-1806, 1981.
Hashimoto, K. Biochem. Biophys. Res. Comm. 230:35-39, 1997.
Darnell, J. Molecular Cell Biology. Scientific American Books, New York, pp. 227-229, 1986.
Halliday, JW. Nutr. Rev. 56(2)S30-S37, 1998.
Camachella, C and Piperno, A. Haematologica 82:77-84, 1997.
Abravaya, K. et al., "Detection of point mutations with a modified ligase chain reaction (Gap-LCR)," Nucl. Acids Res. 23(4):675-682 (1995).
Bacon, B.R., "Causes of Iron Overload," N. Engl. J. Med. 326(2):126-127 (1992).
Barany, F., "Genetic disease detection and DNA amplification using cloned thermostable ligase," Proc. Natl. Acad. Sci. U.S.A. 88:189-193 (1991).
Barton, J.C. et al., "Blood lead concentrations in hereditary hemochromatosis," J. Lab. Clin. Med. 124(2):193-198 (1994).
Barton, J.C. et al., "Hemochromatosis: The genetic disorder of the twenty-first century," Nature Medicine 2(4):394-395 (1996).
Beutler, E. et al., "A Strategy for Cloning the Hereditary Hemochromatosis Gene," Blood Cells. Molecules, and Diseases 21(21):206-216 (1995).
Bjorkman, P.J. et al., "Structure, Function, and Diversity of Class I Major Histocompatibility Complex Molecules," Annu. Rev. Biochem. 59:253-288 (1980).
Calandro, L.M. et al., "Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F," Hum. Genet. 96:339-342 (1995).
Capecchi, M.R. et al., "Altering the Genome by Homologous Recombination," Science 244:1288-1292 (1989).
Cartwright, G.E. et al., "Inheritance of Hemochromatosis: Linkage to HLA," Trans. Assoc. Am. Phys. 91:273-281 (1978).
Chen, X. et al., "Template-directed dye-terminator incorporation (TDI) assay: a homogeneous DNA diagnostic method based on fluorescence resonance energy transfer," Nucl. Acids Res. 25(2):347-353 (1997).
Cotton, R.G.H. et al., "Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations," Proc. Natl. Acad. Sci. U.S.A. 85:4397-4401 (1988).
Crawford, D.H.G. et al., "Evidence that the Ancestral Haplotype in Australian Hemochromatosis Patients May be Associated with a Common Mutation in the Gene," Am. J. Hum. Genet. 57:362-367 (1995).
Crystal, R.G. et al., "Gene Therapy Strategies for Pulmonary Disease," Am. J. Med. 92(6A):6A-44S-6A-51S (1992).
Dugast, I.J. et al., Identification of Two Human Ferritin H Genes on the Short Arm of Chromosome 6,Genomics 6:204-211 (1990).
Edwards, C.Q. et al., "The locus for hereditary homochromatosis maps between HLA-A and HLA-B," Cytogenet. Cell Genet. 40:620 (1985).
Edwards, C.Q. et al., "Screening for Hemochromatosis," New Engl. J. Med. 328(22):1616-1619 (1993).
El Kahloun, A. et al., "Localization of seven new genes around the HLA-A locus," Hum Molec. Genet. 2(1):55-60 (1992).
Fahy, E. et al., "Self-sustained Sequence Replication (3SR): An Isothermal Transcription-based amplification System Alternative to PCR," PCR Methods and Applications 1:25-33 (1991).
Feder J.N. et al., "A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis," Nature Genet. 13:399-408 (1996).
Finch, C.A., "Hemochromatosis--Treatment is Easy, Diagnosis Hard," Western J. Med. 153:323-325 (1990).
Fischer, S.G. et al., "DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory," Proc. Natl. Acad. Sci. U.S.A. 80:1579-1583 (1983).
Friedmann, T., "Progress Toward Human Gene Therapy," Science 244:1275-1281 (1989).
Fullan, A. et al., "A polymorphic dinucleotide repeat at the human HLA-F locus," Hum. Mol. Genet. 3(12):2266.
Gasparini, P. et al., "Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: locatization of the gene centromeric to HLA-F," Hum Molec. Genet. 2(5):571-576 (1993).
Gasparini, P. et al., "Where does the gene for hemochromatosis lie in relation to HLA-A," Hepatology 19:1050-1056 (1994).
Gnirke, A. et al., "Physical Calibration of Yeast Artificial Chromosome Contig Maps by RecA-Assisted Restriction Endonuclease (RARE) Cleavage," Genomics 24:199-210 (1994).
Goei, V.L. et al., "Isolation of Novel Non-HLA Gene Fragments from the Hemochromatosis Region (6p21.3) by cDNA Hybridization Selection," Am. J. Hum. Genet. 54:244-251 (1994).
Gruen, J.R. et al., "Physical and Genetic Mapping of the Telomeric Major Histocompatibility Complex Region in Man and Relevance to the Primary Hemochromatosis," Genomics 14:232-240 (1992).
Gyapay, G. et al., "The 1993-1994 Genethon human genetic linkage map," Nature Genetics 7:246-339 (1994).
Jakobovits, A. et al., "Production of Antigen-Specific Human Antibodies from Mice Engineered with Human Heavy and Light Chain YACs.sup.a ", Ann. N.Y. Acad. Sci. 764:525-535 (1995).
Jazwinska, E.C. et al., "Localization of the Hemochromatosis Gene Close to D6S105," Am. J. Hum. Genet. 53:347-352 (1993).
Jazwinska, E.C. et al., "Haplotype Analysis in Australian Hemochromatosis Patients: Evidence for a Predominant Ancestral Haplotype Exclusively Associated with Hemochromatosis," Am. J. Hum. Genet. 56:428-433 (1995).
Jazwinska, E.C. et al., "Hemochromatosis and `HLA-H`: Definite!", Hepatology, 25(2):495-496 (1997).
Jouet, M.M.H. et al., "Isolation of YAC clones containing class I HLA genes which map in the vicinity of the hereditary haemochromatosis gene," J. Med. Genet. 28(8):572 (1991).
Kan, Y.W. et al., "Antenatal Diagnosis of Sickle-Cell An.ae butted.mia by D.N.A. Analysis of Amniotic-Fluid Cells," Lancet ii:910-911 (1978).
Koller, B.H. et al., "Normal Development of Mice Deficient in .beta..sub.2 M, MHC Class I Proteins, and CD8.sup.+ T Cells, " Science 248:1227-1230 (1990).
Kramer, M.F and Coen, D.M. in Current Protocols in Molecular Biology, Ausubel, F.M. et al., eds., Wiley, Chapter 15 (1994).
Landegren, U. et al., "A Ligase-Mediated Gene Detection Technique," Science 241:1077-1080 (1988).
Lemarchand, P. et al., "Adenovirus-mediated transfer of a recombinant human .alpha..sub.1 -antitrypsin cDNA to human endothelial cells," Proc. Natl. Acad. Sci. U.S.A. 89:6482-6486 (1992).
Lin, A.Y. et al., "Expression of T Cell Antigen Receptor Heterodimers in a Lipid-Linked Form," Science 249:677-679 (1990).
Lipinski, M. et al., "Idiopathic Hemochromatosis: Linkage with HLA," Tissue Antigens 11:471-474 (1978).
Maskos, U. et al., "A novel method for the parallel analysis of multiple mutations in multiple samples," Nucl. Acids Res. 21(9):2269-2270 (1993).
Miyazaki, J. et al., "Intracellular
Drayna Dennis T.
Feder John N.
Gnirke Andreas
Ruddy David
Thomas Winston J.
Bio-Rad Laboratories, Inc.
Saunders David
Tung Mary B.
LandOfFree
Hereditary hemochromatosis gene products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hereditary hemochromatosis gene products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hereditary hemochromatosis gene products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2051870